These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1655106)

  • 21. Human plasma proopiomelanocortin N-terminal peptide and adrenocorticotropin: circadian rhythm, dexamethasone suppression, and corticotropin-releasing hormone stimulation.
    Motomatsu T; Takahashi H; Ibayashi H; Nobunaga M
    J Clin Endocrinol Metab; 1984 Sep; 59(3):495-8. PubMed ID: 6086700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pituitary proopiomelanocortin-derived peptides and hypothalamus-pituitary-interrenal axis activity in gilthead sea bream (Sparus aurata) during prolonged crowding stress: differential regulation of adrenocorticotropin hormone and alpha-melanocyte-stimulating hormone release by corticotropin-releasing hormone and thyrotropin-releasing hormone.
    Rotllant J; Balm PH; Ruane NM; Pérez-Sánchez J; Wendelaar-Bonga SE; Tort L
    Gen Comp Endocrinol; 2000 Aug; 119(2):152-63. PubMed ID: 10936035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of fetal ethanol exposure on pituitary-adrenal sensitivity to secretagogues.
    Osborn JA; Yu C; Stelzl GE; Weinberg J
    Alcohol Clin Exp Res; 2000 Jul; 24(7):1110-9. PubMed ID: 10924017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Desensitization of the hypothalamic-pituitary-adrenal axis following prolonged administration of corticotropin-releasing hormone or vasopressin.
    Tizabi Y; Aguilera G
    Neuroendocrinology; 1992 Nov; 56(5):611-8. PubMed ID: 1336816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The corticotropin-releasing hormone stimulation test: a possible aid in the evaluation of patients with adrenal insufficiency.
    Schulte HM; Chrousos GP; Avgerinos P; Oldfield EH; Gold PW; Cutler GB; Loriaux DL
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1064-7. PubMed ID: 6327750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J; Usui T; Tsukada T; Nakai Y; Koh T; Ishihara T; Tanaka I; Uchida K; Yoshimasa T; Nakano R
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoreactive corticotropin-releasing hormone, adrenocorticotropin and cortisol in human plasma during pregnancy and delivery and postpartum.
    Okamoto E; Takagi T; Makino T; Sata H; Iwata I; Nishino E; Mitsuda N; Sugita N; Otsuki Y; Tanizawa O
    Horm Metab Res; 1989 Oct; 21(10):566-72. PubMed ID: 2553573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of the effects of human and ovine corticotropin-releasing hormone on the pituitary-adrenal axis.
    Trainer PJ; Faria M; Newell-Price J; Browne P; Kopelman P; Coy DH; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 1995 Feb; 80(2):412-7. PubMed ID: 7852498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short-term secretion patterns of corticotropin-releasing hormone, arginine vasopressin and ACTH as shown by intensive sampling of pituitary venous blood from horses.
    Alexander SL; Irvine CH; Donald RA
    Neuroendocrinology; 1994 Sep; 60(3):225-36. PubMed ID: 7969780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats.
    Thomas GB; Fairhall KM; Robinson IC
    Endocrinology; 1997 Apr; 138(4):1585-91. PubMed ID: 9075719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hypothalamic-adenohypophysial function of corticotropin releasing hormone (CRH)-ACTH system in brain death].
    Nishioka H; Ito H; Ikeda Y; Koike S; Ito Y
    No To Shinkei; 1995 Dec; 47(12):1159-63. PubMed ID: 8534552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reset of feedback in the adrenocortical system: an apparent shift in sensitivity of adrenocorticotropin to inhibition by corticosterone between morning and evening.
    Akana SF; Cascio CS; Du JZ; Levin N; Dallman MF
    Endocrinology; 1986 Nov; 119(5):2325-32. PubMed ID: 3021439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pituitary and adrenocortical responses to the ovine corticotropin releasing hormone in depressed patients and healthy volunteers.
    Amsterdam JD; Maislin G; Winokur A; Kling M; Gold P
    Arch Gen Psychiatry; 1987 Sep; 44(9):775-81. PubMed ID: 2820340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blunted adrenocorticotropin and increased adrenal steroid response to human corticotropin-releasing hormone in Alzheimer's disease.
    Näsman B; Olsson T; Fagerlund M; Eriksson S; Viitanen M; Carlström K
    Biol Psychiatry; 1996 Mar; 39(5):311-8. PubMed ID: 8704061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthetic ovine corticotropin-releasing hormone: simultaneous release of proopiolipomelanocortin peptides in man.
    Jackson RV; DeCherney GS; DeBold CR; Sheldon WR; Alexander AN; Rivier J; Vale W; Orth DN
    J Clin Endocrinol Metab; 1984 Apr; 58(4):740-3. PubMed ID: 6321535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Corticotropin-releasing hormone links pituitary adrenocorticotropin gene expression and release during adrenal insufficiency.
    Muglia LJ; Jacobson L; Luedke C; Vogt SK; Schaefer ML; Dikkes P; Fukuda S; Sakai Y; Suda T; Majzoub JA
    J Clin Invest; 2000 May; 105(9):1269-77. PubMed ID: 10792002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of pyridostigmine, corticotropin-releasing hormone and growth hormone-releasing hormone on the pituitary-adrenal axis and on growth hormone secretion in dementia.
    Murialdo G; Fonzi S; Torre F; Costelli P; Solinas G; Tosca P; Di Paolo E; Porro S; Zerbi F; Polleri A
    Neuropsychobiology; 1993; 28(4):177-83. PubMed ID: 8272199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diurnal variation in the response of plasma adrenocorticotropin and cortisol to intravenous ovine corticotropin-releasing hormone.
    DeCherney GS; DeBold CR; Jackson RV; Sheldon WR; Island DP; Orth DN
    J Clin Endocrinol Metab; 1985 Aug; 61(2):273-9. PubMed ID: 2989316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of immunoneutralization of corticotropin-releasing hormone on ultradian rhythms of plasma adrenocorticotropin.
    Carnes M; Lent SJ; Goodman B; Mueller C; Saydoff J; Erisman S
    Endocrinology; 1990 Apr; 126(4):1904-13. PubMed ID: 2156671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ovine corticotropin-releasing hormone stimulation test in normal children.
    Ross JL; Schulte HM; Gallucci WT; Cutler GB; Loriaux DL; Chrousos GP
    J Clin Endocrinol Metab; 1986 Feb; 62(2):390-2. PubMed ID: 3001126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.